A4852: Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*
New Jersey Senate, June 30, 2026. 3RDG FINAL PASSAGE, roll call 317: 38 yes, 2 no, 0 abstained, 0 not voting.
Signed into law: P.L.2026, c.40 (July 8, 2026).
Prime sponsors: Andrea Katz, Marisa Sweeney, Vincent M. Kearney, Chris Tully, Joseph F. Vitale, Vin Gopal, Raj Mukherji.
Bill documents
- Text of P.L.2026, c.40
- Assembly committee substitute (Assembly State and Local Government Committee, Jun 23, 2026)
- Bill text as introduced
- Committee statement (Assembly State and Local Government Committee, Jun 23, 2026)
How they voted
Yes (38)
- Amato, Carmen F.
- Beach, James
- Bramnick, Jon M.
- Bucco, Anthony M.
- Burgess, Renee C.
- Burzichelli, John J.
- Cruz-Perez, Nilsa I.
- Cryan, Joseph P.
- Diegnan, Patrick J.
- Gopal, Vin
- Greenstein, Linda R.
- Henry, Owen
- Holzapfel, James W.
- Johnson, Gordon M.
- Lagana, Joseph A.
- McKeon, John F.
- McKnight, Angela V.
- Moriarty, Paul D.
- Mukherji, Raj
- O'Scanlon, Declan J.
- Pennacchio, Joseph
- Polistina, Vincent J.
- Ruiz, M. Teresa
- Sarlo, Paul A.
- Scutari, Nicholas P.
- Singer, Robert W.
- Singleton, Troy
- Smith, Bob
- Space, Parker
- Stack, Brian P.
- Steinhardt, Douglas J.
- Testa, Michael L.
- Timberlake, Britnee N.
- Tiver, Latham
- Turner, Shirley K.
- Vitale, Joseph F.
- Wimberly, Benjie E.
- Zwicker, Andrew
No (2)
- Corrado, Kristin M.
- Schepisi, Holly T.
A4852 on the New Jersey Legislature website
Independent, unofficial recreation built from NJ Legislature data. This is not a government website, and no state time or resources were used.